UP-22.47: Role of Systematic Biopsies in Suspected Carcinoma Prostate Patients and Analysis of Gleason Grade Group Concordance Between the Biopsy and Histopathology Report Following Radical Prostatectomy
MP-22.01: A Head-to-Head Comparison of Micro-Ultrasound Guided Cognitive Prostate Biopsy and Conventional Robotic Assisted MRI-Fusion Prostate Biopsy in an Asian Setting
Presenting Author: Thomas Chan – Sengkang General Hospital, Singhealth
Prostate Cancer - Detection
Thursday, Oct 30th
08:00 - 09:00 GMT+0
MP-22.02: A Highly Sensitive Methylation Assay for Prostate Cancer Diagnosis
Presenting Author: Xingyu Zhong – Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology
Prostate Cancer - Detection
Thursday, Oct 30th
08:00 - 09:00 GMT+0
MP-22.03: A Machine Learning Approach for Predicting Prostate Cancer Gleason Grade Group at Radical Prostatectomy
Presenting Author: Adam S. Feldman – Massachusetts General Hospital
Prostate Cancer - Detection
Thursday, Oct 30th
08:00 - 09:00 GMT+0
MP-22.04: A Photoactivatable Methylation Detection System Enables Cost-Effective Liquid Biopsy for Prostate Cancer Diagnosis
Presenting Author: Xingyu Zhong – Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology
Prostate Cancer - Detection
Thursday, Oct 30th
08:00 - 09:00 GMT+0
MP-22.05: An AI-Augmented Logistic Regression Model for Prostate Cancer Diagnosis: Integrating Race-Specific Gene Expression Profiling with Deep Feature Optimization
MP-22.06: Comparative Performance of the Camprobe Double Freehand Local Anaesthesia Transperineal Biopsy Device versus in Line Guides for Detection of Significant Prostate Cancer - a Two Centre Study
Presenting Author: Adham Ahmed – West Suffolk Hospital
Prostate Cancer - Detection
Thursday, Oct 30th
08:00 - 09:00 GMT+0
MP-22.07: Cross-Sectional Study and Mendelian Randomization Study Exploring the Associations of Serum Folic Acid and Risk of Prostate Cancer
Presenting Author: Guobing Xiong – Department of Urology, Sanya Central Hospital (Hainan Third People's Hospital), Hainan Medical University
Prostate Cancer - Detection
Thursday, Oct 30th
08:00 - 09:00 GMT+0
MP-22.08: Deep Learning Network Enhances Imaging Quality of Low-B-Value Diffusion-Weighted Imaging and Improves Lesion Detection in Prostate Cancer
Presenting Author: Zheng Liu – Fudan University Shanghai Cancer Center
Prostate Cancer - Detection
Thursday, Oct 30th
08:00 - 09:00 GMT+0
MVP-22.01: Micro-Ultrasound-Guided Cognitive Transperineal Biopsy of the Prostate: a Step-by-Step Guide
Presenting Author: Thomas Chan – Sengkang General Hospital, Singhealth
Prostate Cancer - Detection
Friday, Oct 31st
08:00 - 09:00 GMT+0
MP-22.09: Diagnostic Performance of 68ga-PSMA-PET and MRI Fusion-Based Cognitive Biopsy in Patients with Suspected Prostate Cancer: a Pilot Study
Presenting Author: Sanjay Kumar – All India Institute of Medical Sciences, New Delhi
Prostate Cancer - Detection
Friday, Oct 31st
08:00 - 09:00 GMT+0
MP-22.10: Evaluating Interobserver Variability in Reporting of Surgical Margin Status in Men Undergoing Radical Prostatectomy: Analysis From the Ip8-Fluoresce Study
Presenting Author: Samuel Morris – Imperial College Healthcare NHS Trust
Prostate Cancer - Detection
Friday, Oct 31st
08:00 - 09:00 GMT+0
MP-22.11: Global Disparities in Prostate Cancer Burden: Temporal Dynamics and Socioeconomic Correlates (1990-2021)
Presenting Author: Xianghong Zhou – West China Hospital, Sichuan University
Prostate Cancer - Detection
Friday, Oct 31st
08:00 - 09:00 GMT+0
MP-22.12: Impact of Routine Histopathological Examination on Management of Prostate Cancer Patients Undergoing Transurethral Resection of the Prostate (TURP) or Holmium Laser Enucleation of the Prostate (HoLEP)
Presenting Author: Momen Sid Ahmed – Princess Royal University Hospital, King's College Hospital NHS Trust, London, UK
Prostate Cancer - Detection
Friday, Oct 31st
08:00 - 09:00 GMT+0
MP-22.13: Innovative Personalised Prioritisation Pathway for Improved Timely Prostate Cancer Diagnosis in Scotland
Prostate Cancer - Detection
Friday, Oct 31st
08:00 - 09:00 GMT+0
MP-22.14: Integrating Multi-Cohort Machine Learning and Clinical Validation to Explore Peripheral Blood mRNA Diagnostic Biomarkers for Prostate Cancer
Presenting Author: Xi Gong – Huazhong University of Science and Technology (HUST)
Prostate Cancer - Detection
Friday, Oct 31st
08:00 - 09:00 GMT+0
MP-22.15: MRI-Guided Biopsy versus 24-Core Transperineal Systematic Biopsy for Clinically Significant Prostate Cancer Detection: Final Results of the Randomized Controlled Trial (Smart)
Presenting Author: Peter Chiu – The Chinese University of Hong Kong
Prostate Cancer - Detection
Friday, Oct 31st
08:00 - 09:00 GMT+0
MP-22.16: Prostate Health Index Combined with Pi-Rads Score Enhances Prostate Cancer Diagnosis: Insights From a Large Chinese Cohort
Presenting Author: Qidong Xia – Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Prostate Cancer - Detection
Friday, Oct 31st
08:00 - 09:00 GMT+0
MP-22.17: Recalibrating Prostate Cancer Diagnostics in 5-Alpha Reductase Inhibitor Users: a Meta-Analysis of 38 Studies
MP-22.18: Retrospective Comparison of Conventional Transrectal and 29-Mhz Micro- Ultrasound-Guided Biopsy for Prostate Cancer Detection at a German University Hospital
Prostate Cancer - Detection
Friday, Oct 31st
08:00 - 09:00 GMT+0
MP-22.19: Risk of Prostate Cancer in Asian American Men
MP-22.20: Role of Confirmatory General Anaesthetic Transperineal Biopsy in Patients Considering Active Surveillance for Prostate Cancer: a Single-Centre Retrospective Review
Prostate Cancer - Detection
Friday, Oct 31st
08:00 - 09:00 GMT+0
MP-22.22: Sensitivity/specificity per Target Quadrant vs Whole Prostate of Biparametric MRI-Based Transperineal Prostate Biopsy
MP-22.23: Trans-Perineal MR/US Fusion Prostate Biopsy: Evaluating the Benefits of Targeted Biopsy Alone vs. Targeted Plus Random Biopsy in Diagnosing Clinically Significant Disease.
Prostate Cancer - Detection
Saturday, Nov 1st
08:00 - 09:00 GMT+0
RF-22.01: Concordance of Bpmri and mpMRI in Assessment of Radiological Staging, Extra-Capsular Extension and Key Prostate Cancer Involvement Sites - an Analysis of the Prime Trial
RF-22.07: Risk Factors for Incidental Prostate Cancer Following Surgery for Benign Prostatic Enlargement: a Systematic Review and Meta-Analysis
Presenting Author: Angelo Cormio – Università Politecnica delle Marche
Prostate Cancer - Detection
Saturday, Nov 1st
08:00 - 09:00 GMT+0
RF-22.08: The Impact of Radiologist Experience on Clinically Significant Prostate Cancer Detection on Biparametric and Multiparametric MRI - an Analysis of the Prime Trial
